Favorable effect on acute and chronic graft-versus-host disease with cyclophosphamide and in vivo anti-CD52 monoclonal antibodies for marrow transplantation from HLA-identical sibling donors for acquired aplastic anemia

This publication has 36 references indexed in Scilit:

• Guidelines for the diagnosis and management of acquired aplastic anaemia
  British Journal of Haematology, 2003
• Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: The experience in four centers
  Transplantation and Cellular Therapy, 2001
• Current status of allogeneic bone marrow transplantation in acquired aplastic anemia
  Seminars in Hematology, 2000
• Treatment of acquired severe aplastic anemia: Bone marrow transplantation compared with immunosuppressive therapy-the European group for blood and marrow transplantation experience
  Seminars in Hematology, 2000
• Long-Term Follow-Up of Allogeneic Marrow Transplants in Patients With Aplastic Anemia Conditioned by Cyclophosphamide Combined With Antithymocyte Globulin
  Blood, 1997
• Primary Treatment of Acquired Aplastic Anemia: Outcomes with Bone Marrow Transplantation and Immunosuppressive Therapy
  Annals of Internal Medicine, 1997
• Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia
  Blood, 1994
• Graft failure following bone marrow transplantation for severe aplastic anemia: risk factors and treatment results
  Blood, 1989
• Second marrow transplants in patients with aplastic anemia rejecting the first graft: use of a conditioning regimen including cyclophosphamide and antithymocyte globulin
  Blood, 1987
• Marrow Transplantation for Treatment of Aplastic Anemia
  New England Journal of Medicine, 1977